- Home
- FCF vs VCEL Comparison
FCF vs VCEL Comparison
Compare FCF & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCF
- VCEL
- Stock Information
- Founded
- FCF 1934
- VCEL 1989
- Country
- FCF United States
- VCEL United States
- Employees
- FCF N/A
- VCEL N/A
- Industry
- FCF Major Banks
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FCF Finance
- VCEL Health Care
- Exchange
- FCF Nasdaq
- VCEL Nasdaq
- Market Cap
- FCF 1.6B
- VCEL 1.8B
- IPO Year
- FCF N/A
- VCEL 1997
- Fundamental
- Price
- FCF $16.13
- VCEL $39.31
- Analyst Decision
- FCF Buy
- VCEL Strong Buy
- Analyst Count
- FCF 6
- VCEL 6
- Target Price
- FCF $19.50
- VCEL $60.40
- AVG Volume (30 Days)
- FCF 692.7K
- VCEL 609.5K
- Earning Date
- FCF 10-28-2025
- VCEL 11-06-2025
- Dividend Yield
- FCF 3.35%
- VCEL N/A
- EPS Growth
- FCF N/A
- VCEL 236.54
- EPS
- FCF 1.39
- VCEL 0.25
- Revenue
- FCF $468,728,000.00
- VCEL $258,716,999.00
- Revenue This Year
- FCF $17.60
- VCEL $18.35
- Revenue Next Year
- FCF $7.34
- VCEL $22.26
- P/E Ratio
- FCF $11.59
- VCEL $160.33
- Revenue Growth
- FCF 2.69
- VCEL 14.05
- 52 Week Low
- FCF $13.54
- VCEL $29.24
- 52 Week High
- FCF $19.96
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- FCF 53.15
- VCEL 58.44
- Support Level
- FCF $15.30
- VCEL $37.51
- Resistance Level
- FCF $16.21
- VCEL $41.66
- Average True Range (ATR)
- FCF 0.36
- VCEL 1.83
- MACD
- FCF 0.05
- VCEL -0.14
- Stochastic Oscillator
- FCF 84.38
- VCEL 50.53
About FCF First Commonwealth Financial Corporation
First Commonwealth Financial Corp functions in the financial services sector in the United States. Through its subsidiary, it offers a range of consumer and commercial banking services such as personal checking accounts, interest-earning checking accounts, savings accounts, insured money market accounts, investment certificates, fixed & variable rate certificates of deposit, and various kinds of loans. It also provides trust and wealth management services and offers insurance products. The company earns the majority of its revenue through net interest income.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.